Skip to content
Abierto

Combined synopsis and solicitation

Notice of Intent to Sole Source - Luminex xMAP Assays

86177

Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Analytical Laboratory Instrument Manufacturing.

Response deadline

May 8, 2024 at 9:00 AM EDT

Closed 863 days ago. Posted May 6, 2024. Scheduled to archive May 8, 2024.

Description

As published on SAM.gov.

The Luminex xMAP technology that is utilized in Luminex assays to precisely measure multiple analytes simultaneously in one sample. The color-coded bead-based assays use internally dyed beads that correspond to a distinct spectral signature from which bead-bound antibodies specific to target analytes can be detected and quantified. Additionally, these assays undergo multiple quality control steps to ensure long-term reproducibility and consistency and requires only a small sample volume.

These assays have been optimized and validated for optimal performance. The antibodies used are specific to each target and have been confirmed to have little cross-over, which limits variability between assays. The specificity and reproducibility of this assay is not offered using other products.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 6, 2024

    Combined synopsis and solicitation

    Due May 8, 2024 at 9:00 AM EDT. SAM.gov, notice 8aed906ac90649f1a43c272e8a1aedc5

Points of contact